Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Receivables: 2022-2025

Historic Receivables for NewGenIvf (NIVF) over the last 4 years, with Sep 2025 value amounting to $185.9 billion.

  • NewGenIvf's Receivables was N/A to $185.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $185.9 billion, marking a year-over-year change of. This contributed to the annual value of $170,797 for FY2024, which is 575.01% up from last year.
  • Latest data reveals that NewGenIvf reported Receivables of $185.9 billion as of Q3 2025, which was up 292,458,251.03% from $63,567 recorded in Q2 2025.
  • Over the past 5 years, NewGenIvf's Receivables peaked at $185.9 billion during Q3 2025, and registered a low of $25,303 during Q4 2023.
  • For the 3-year period, NewGenIvf's Receivables averaged around $46.5 billion, with its median value being $117,182 (2024).
  • Its Receivables has fluctuated over the past 5 years, first plummeted by 41.59% in 2023, then skyrocketed by 575.01% in 2024.
  • Over the past 4 years, NewGenIvf's Receivables (MRQ) stood at $43,321 in 2022, then tumbled by 41.59% to $25,303 in 2023, then skyrocketed by 575.01% to $170,797 in 2024, then skyrocketed by 108,846,659.60% to $185.9 billion in 2025.
  • Its Receivables stands at $185.9 billion for Q3 2025, versus $63,567 for Q2 2025 and $170,797 for Q4 2024.